In a discovery that could redefine the future of cancer immunotherapy, scientists from Celloram Inc., University Hospitals and Case Western Reserve University have developed a novel cancer vaccine platform that transforms the impact of the largest immunological event in modern history—a synchronized mass immune memory generated through SARS-CoV-2 infection and vaccination—into a powerful ally against cancer.
This article was originally published by MedicalXpress. For more details, images, and references:
Read Full Original Article ↗